Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.23 Delayed Data As of Jul 06 |  +0.07 / +6.03%Today’s Change | 0.80 Today|||52-Week Range 3.66 | -30.40% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Scopa James Paul Director |  Sale | 11/15/2021 | 50,000 | $2.18 | $109.0K | -43.32% |
Soparkar Peter N/A |  Buy | 12/08/2021 | 25,000 | $1.91 | $47.8K | -34.22% |
Fischer Laurent | Buy | 4/20/2022 | 25,000 | $1.11 | $27.8K | +7.89% |
Fischer Laurent | Buy | 12/09/2021 | 14,323 | $1.85 | $26.5K | -33.15% |
Svoronos Dawn A Director | Buy | 5/16/2022 | 30,000 | $0.85 | $25.5K | +51.91% |
Soparkar Peter N/A | Buy | 4/19/2022 | 21,750 | $1.14 | $24.8K | +9.82% |
Fischer Laurent | Buy | 12/08/2021 | 10,677 | $1.79 | $19.1K | -34.22% |
Seyedkazemi Star Chief Development Officer | Buy | 5/23/2022 | 20,000 | $0.84 | $16.8K | +48.91% |
Clark Julie /adverum/ Chief Medical Officer | Sale | 9/30/2021 | 4,766 | $2.17 | $10.3K | -43.32% |
Dsouza Rupert Chief Financial Officer | Buy | 5/13/2022 | 10,000 | $0.86 | $8.6K | +47.22% |
Page of 2